Related Experiment Video

Updated: Jan 6, 2026

Isolation and Analysis of Plasma Lipoproteins by Ultracentrifugation
06:47

Isolation and Analysis of Plasma Lipoproteins by Ultracentrifugation

Published on: January 28, 2021

12.3K

Lipoprotein(a) - Link between Atherogenesis and Thrombosis

Danica Labudovic1, Irena Kostovska2, Katerina Tosheska Trajkovska1

  • 1Department of Medical and Experimental Biochemistry, Faculty of Medicine, Ss. Cyril and Methodius University in Skopje, Skopje, North Macedonia.

Prague Medical Report
|October 7, 2019
PubMed

Insights

Lipoprotein(a) (Lp(a)) is a key risk factor for cardiovascular disease (CVD). Understanding Lp(a)"s molecular mechanisms is crucial for developing targeted therapies beyond costly apheresis.

Area of Science:

  • Cardiovascular biology
  • Molecular medicine
  • Lipidology

Background:

  • Lipoprotein(a) (Lp(a)) is an independent risk factor for cardiovascular disease (CVD).
  • Elevated Lp(a) levels (> 200 mg/l) significantly increase CVD risk.
  • Lp(a) levels are resistant to conventional lipid-lowering treatments, with plasma apheresis being the primary intervention.

Purpose of the Study:

  • To elucidate the cellular effects and molecular mechanisms of Lp(a) in cardiovascular pathology.
  • To identify therapeutic targets for mitigating Lp(a)-mediated vascular damage.
  • To understand Lp(a)'s role in atherogenesis, thrombogenesis, and inflammation.

Main Methods:

  • Review of existing literature on Lp(a) structure and function.
  • Analysis of molecular interactions between Lp(a) and vascular components.
  • Summary of cellular pathways implicated in Lp(a)-driven cardiovascular disease.

Main Results:

  • Lp(a) comprises an LDL/apoB-100 core and an apolipoprotein(a) (Apo(a)) component.
  • Both core and Apo(a) interact with coagulation and inflammatory pathways.
  • Lp(a) influences vascular cells, including smooth muscle and endothelial cells.

Conclusions:

  • Lp(a) actively participates in atherogenesis, thrombogenesis, and inflammation.
  • Targeting Lp(a)'s cellular effects is essential for novel therapeutic strategies.
  • Further research into Lp(a) molecular pathways can lead to effective CVD treatments.

Keywords:
AtherogenicityCardiovascular diseaseLp(a)Thrombogenicity

More Related Videos

Cell-free Biochemical Fluorometric Enzymatic Assay for High-throughput Measurement of Lipid Peroxidation in High Density Lipoprotein07:29

Cell-free Biochemical Fluorometric Enzymatic Assay for High-throughput Measurement of Lipid Peroxidation in High Density Lipoprotein

Published on: October 12, 2017

9.7K
Differential Effects of Lipid-lowering Drugs in Modulating Morphology of Cholesterol Particles09:15

Differential Effects of Lipid-lowering Drugs in Modulating Morphology of Cholesterol Particles

Published on: November 10, 2017

15.0K

Related Concept Videos

Atherosclerosis I: Introduction01:30

Atherosclerosis I: Introduction

Atherosclerosis is a progressive disorder characterized by the buildup of plaques on the arterial inner wall, causing them to narrow and harden over time. These plaques comprise lipids, calcium, blood components, carbohydrates, and fibrous tissue. The process primarily affects the intima of large and medium-sized arteries, reducing blood flow in any artery.Etiology and risk factorsThe cause of atherosclerosis is multifactorial, involving a complex interplay among endothelial injury, lipid...
738
Blood Studies for Cardiovascular System III: Serum Lipid Profile01:25

Blood Studies for Cardiovascular System III: Serum Lipid Profile

Understanding serum lipids is crucial for maintaining cardiovascular health and preventing heart disease and stroke.
Serum lipids are fats and fatty substances in the blood and are crucial for various bodily functions, including energy storage, cellular structure, and hormone production. Serum lipids consist of cholesterol, triglycerides, and phospholipids.
Cholesterol is a soft, fat-like substance found in all body cells. It is crucial for producing hormones, vitamin D, and substances that aid...
532
Inflammation01:38

Inflammation

Overview
61.4K
Atherosclerosis III: Management01:26

Atherosclerosis III: Management

Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
290
Peripheral Artery Disease I: Introduction01:30

Peripheral Artery Disease I: Introduction

Peripheral artery disease (PAD) predominantly results from atherosclerosis, which involves the accumulation of fatty deposits, or plaques, within the walls of arteries. This causes them to narrow and harden, significantly reducing blood flow. PAD predominantly affects the legs, particularly the arteries supplying the thighs and calves. In rare cases, it may involve other arteries, including those in the arms.Etiology of PAD:The principal cause of PAD is atherosclerosis, which results from fatty...
275
Cholesterol: Significance and Regulation01:29

Cholesterol: Significance and Regulation

Although not a source of energy, cholesterol plays a significant role as a foundational structure for bile salts, steroid hormones, and vitamin D, as well as being a crucial component of plasma membranes. Approximately 15% of blood cholesterol is derived from our diet, with the remainder synthesized from acetyl CoA by the liver and intestines. Cholesterol is eliminated from the body through its conversion into bile salts, which are eventually discarded in the feces.
Considering cholesterol and...
1.2K